(Q48471657)

English

D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after

scientific article published in May 1998

D2 Dopamine Receptor Up-Regulation, Treatment Response, Neurological Soft Signs, and Extrapyramidal Side Effects in Schizophrenia: A Follow-Up Study with 123I-Iodobenzamide Single Photon Emission Computed Tomography in the Drug-Naive State and after

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

0 references

extrapyramidal symptoms

1 reference

based on heuristic

inferred from title

author name string

Schröder J

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Silvestri S

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Bubeck B

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Karr M

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Demisch S

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Scherrer S

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Geider FJ

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Sauer H

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Biological Psychiatry

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

43

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

9

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

660-665

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Increased brain dopamine and dopamine receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Abnormal movements in never-medicated Indian patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Neurological soft signs in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Memory deficits in subsyndromes of chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

[123I]IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900442-3

7 January 2021

Identifiers

10.1016/S0006-3223(97)00442-3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9582999

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48471657&oldid=2109358465"